Yesterday, April 4, 2016, 48 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $300.52 to $2,835,525.00.

Highlighted Stocks Traded by Insiders:

Endurance International Group Holdings (EIGI) - FREE Research Report

Andreasen Katherine J, who is Chief Administrative Officer at Endurance International Group Holdings, sold 2,100 shares at $11.15 on April 4, 2016. Following this transaction, the Chief Administrative Officer owned 73,667 shares meaning that the stake was reduced by 2.77% with the 2,100-share transaction.

Mathews Timothy S, who is Chief Accounting Officer at Endurance International Group Holdings, sold 925 shares at $11.20 on April 4, 2016. Following this transaction, the Chief Accounting Officer owned 24,887 shares meaning that the stake was reduced by 3.58% with the 925-share transaction.

Bryson David C, who is Chief Legal Officer at Endurance International Group Holdings, sold 1,575 shares at $11.16 on April 4, 2016. Following this transaction, the Chief Legal Officer owned 332,231 shares meaning that the stake was reduced by 0.47% with the 1,575-share transaction.

LaSalvia Ronald, who is President and COO at Endurance International Group Holdings, sold 4,195 shares at $11.22 on April 4, 2016. Following this transaction, the President and COO owned 210,694 shares meaning that the stake was reduced by 1.95% with the 4,195-share transaction.

The shares most recently traded at $10.15, down $1.07, or 10.56% since the insider transaction. Historical insider transactions for Endurance International Group Holdings go as follows:

  • 4-Week # shares sold: 7,717
  • 12-Week # shares sold: 7,717
  • 24-Week # shares bought: 15,000
  • 24-Week # shares sold: 7,717

The average volume for Endurance International Group Holdings has been 557,000 shares per day over the past 30 days. Endurance International Group Holdings has a market cap of $1.4 billion and is part of the technology sector and computer software & services industry. Shares are up 3.11% year-to-date as of the close of trading on Monday.

Endurance International Group Holdings, Inc., together with its subsidiaries, provides cloud-based platform solutions for small-and medium-sized businesses worldwide. Currently, there are 4 analysts who rate Endurance International Group Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EIGI - FREE

TheStreet Quant Ratings

rates Endurance International Group Holdings as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, generally high debt management risk and generally disappointing historical performance in the stock itself. Get the full

Endurance International Group Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Oracle (ORCL) - FREE Research Report

Fowler John F, who is EVP, Systems at Oracle, sold 14,971 shares at $40.92 on April 4, 2016. Following this transaction, the EVP, Systems owned 5,016 shares meaning that the stake was reduced by 74.9% with the 14,971-share transaction.

The shares most recently traded at $40.82, down $0.10, or 0.24% since the insider transaction. Historical insider transactions for Oracle go as follows:

  • 4-Week # shares sold: 3,477
  • 12-Week # shares sold: 3,477
  • 24-Week # shares sold: 3,477

The average volume for Oracle has been 17.2 million shares per day over the past 30 days. Oracle has a market cap of $170.8 billion and is part of the technology sector and computer software & services industry. Shares are up 12.43% year-to-date as of the close of trading on Monday.

Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide. The stock currently has a dividend yield of 1.46%. The company has a P/E ratio of 25.2. Currently, there are 12 analysts who rate Oracle a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ORCL - FREE

TheStreet Quant Ratings

rates Oracle as a

buy

. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, expanding profit margins, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Oracle Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Mylan (MYL) - FREE Research Report

Maroon Joseph C Md, who is Director at Mylan, bought 4,337 shares at $46.36 on April 4, 2016. Following this transaction, the Director owned 16,124 shares meaning that the stake was boosted by 36.79% with the 4,337-share transaction.

The shares most recently traded at $45.87, down $0.49, or 1.07% since the insider transaction. Historical insider transactions for Mylan go as follows:

  • 4-Week # shares bought: 3,895
  • 4-Week # shares sold: 34,579
  • 12-Week # shares bought: 17,082
  • 12-Week # shares sold: 34,579
  • 24-Week # shares bought: 17,082
  • 24-Week # shares sold: 34,579

The average volume for Mylan has been 6.1 million shares per day over the past 30 days. Mylan has a market cap of $23.3 billion and is part of the health care sector and drugs industry. Shares are down 12.65% year-to-date as of the close of trading on Monday.

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company has a P/E ratio of 41.0. Currently, there are 5 analysts who rate Mylan a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MYL - FREE

TheStreet Quant Ratings

rates Mylan as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Mylan Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.